Research ArticleBasic Science Investigations
PET with the 89Zr-Labeled Transforming Growth Factor-β Antibody Fresolimumab in Tumor Models
Thijs H. Oude Munnink, Marlous E.A. Arjaans, Hetty Timmer-Bosscha, Carolina P. Schröder, Jan W. Hesselink, Silke R. Vedelaar, Annemiek M.E. Walenkamp, Michael Reiss, Richard C. Gregory, Marjolijn N. Lub-de Hooge and Elisabeth G.E. de Vries
Journal of Nuclear Medicine December 2011, 52 (12) 2001-2008; DOI: https://doi.org/10.2967/jnumed.111.092809
Thijs H. Oude Munnink
Marlous E.A. Arjaans
Hetty Timmer-Bosscha
Carolina P. Schröder
Jan W. Hesselink
Silke R. Vedelaar
Annemiek M.E. Walenkamp
Michael Reiss
Richard C. Gregory
Marjolijn N. Lub-de Hooge
Elisabeth G.E. de Vries
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 52, Issue 12
December 1, 2011
PET with the 89Zr-Labeled Transforming Growth Factor-β Antibody Fresolimumab in Tumor Models
Thijs H. Oude Munnink, Marlous E.A. Arjaans, Hetty Timmer-Bosscha, Carolina P. Schröder, Jan W. Hesselink, Silke R. Vedelaar, Annemiek M.E. Walenkamp, Michael Reiss, Richard C. Gregory, Marjolijn N. Lub-de Hooge, Elisabeth G.E. de Vries
Journal of Nuclear Medicine Dec 2011, 52 (12) 2001-2008; DOI: 10.2967/jnumed.111.092809
PET with the 89Zr-Labeled Transforming Growth Factor-β Antibody Fresolimumab in Tumor Models
Thijs H. Oude Munnink, Marlous E.A. Arjaans, Hetty Timmer-Bosscha, Carolina P. Schröder, Jan W. Hesselink, Silke R. Vedelaar, Annemiek M.E. Walenkamp, Michael Reiss, Richard C. Gregory, Marjolijn N. Lub-de Hooge, Elisabeth G.E. de Vries
Journal of Nuclear Medicine Dec 2011, 52 (12) 2001-2008; DOI: 10.2967/jnumed.111.092809
Jump to section
Related Articles
Cited By...
- Colocalized targeting of TGF-{beta} and PD-L1 by bintrafusp alfa elicits distinct antitumor responses
- TGF-{beta} Antibody Uptake in Recurrent High-Grade Glioma Imaged with 89Zr-Fresolimumab PET
- PET/CT-Derived Whole-Body and Bone Marrow Dosimetry of 89Zr-Cetuximab
- Interrogating Tumor Metabolism and Tumor Microenvironments Using Molecular Positron Emission Tomography Imaging. Theranostic Approaches to Improve Therapeutics
- Placental Growth Factor (PlGF)-Specific Uptake in Tumor Microenvironment of 89Zr-Labeled PlGF Antibody RO5323441
- Advances in Immuno-Positron Emission Tomography: Antibodies for Molecular Imaging in Oncology
- Molecular Imaging of Tumors with Radioactive Labeled Antibodies from Laboratory to the Clinic